Background & Sources: Prognosis and treatment of Tysabri-related Progressive Multifocal Leukoencephalopathy

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

In-depth resource

A Closer Look at Prognosis and treatment of Tysabri-related Progressive Multifocal Leukoencephalopathy

In-depth context and analysis on this topic for researchers and advocates.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

Mayo Clinic — Diseases & Conditions

Reference: Mayo Clinic — Diseases & Conditions

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.